Cold chain monitoring solutions for pharmaceutical supply chains with real-time monitoring devices, data loggers, cloud-enabled visibility platforms, and automated product release evaluations.
Sensitech, a Carrier Global Corporation company since 2006, provides cold chain monitoring solutions for temperature-sensitive pharmaceutical supply chains. The platform combines real-time monitoring devices (SmartMonitor, SmartView), data loggers (Q-tag, TempTale Ultra), and cloud-enabled visibility platforms (Lynx Digital Platform, ColdStream Select) to ensure product integrity throughout transit and storage.
With 570+ employees across 6 continents, Sensitech serves pharmaceutical and life sciences companies requiring GxP-compliant temperature monitoring for temperature-sensitive shipments. The platform offers full traceability for regulatory compliance, GDP pharmaceutical regulations support, and end-to-end risk mitigation through continuous monitoring and automated alerting.
In March 2025, Sensitech launched Lynx FacTOR, a SaaS solution that automates end-to-end product release evaluations for pharmaceutical cold chain shipments. FacTOR consolidates data from multiple sources to assess temperature excursions, batch stability data, and compliance requirements in minutes instead of days. The platform is device-agnostic, 21 CFR Part 11-compliant, and integrates with existing monitoring devices and data sources.
Sensitech states that Carrier holds the largest market share in global cold chain monitoring through Sensitech and the Lynx Digital Platform. The company expanded capabilities through the August 2024 acquisition of the Monitoring Solutions business from Berlinger & Co. AG, and a partnership with Qualcomm Technologies for enhanced real-time connectivity.
Pharmaceutical Edition
Sensitech offers pharmaceutical-specific cold chain solutions including ColdStream Select for end-to-end cloud-based risk mitigation of temperature-sensitive life sciences shipments, and Lynx FacTOR (launched March 2025) for automated pharmaceutical product release evaluations. The platform provides GxP compliance support, GDP pharmaceutical regulations adherence, and full traceability for regulatory compliance. Sensitech markets its cold chain solutions as validated. Validation documentation availability and pre-validated status are undisclosed. TempTale Ultra devices are marketed as compact, accurate, easy-to-understand, and cost-effective temperature monitoring for pharmaceutical applications.
Core Capabilities
FDA & GxP Compliance
Sensitech provides cloud-enabled SaaS platforms (Lynx Digital Platform, Lynx FacTOR) with device-agnostic architecture supporting multiple monitoring technologies including real-time SmartMonitor/SmartView devices and TempTale Ultra/Q-tag data loggers. ColdStream Select offers end-to-end cloud-based monitoring and risk mitigation with centralized visibility across the pharmaceutical supply chain.
Lynx FacTOR, launched March 2025, operates as pure SaaS with device-agnostic data consolidation from multiple sources including monitoring devices, batch stability databases, and compliance systems. Platform integrates with existing monitoring infrastructure and data sources for automated product release evaluations. Enhanced real-time connectivity enabled through Qualcomm Technologies partnership for improved monitoring, intelligence, and response capabilities.
Technical capabilities include 21 CFR Part 11-compliant data handling (Lynx FacTOR), full traceability for regulatory compliance, supply chain data protection, and cold chain solutions Sensitech markets as validated. Platform designed for pharmaceutical and life sciences companies with global operations requiring GxP compliance support and GDP pharmaceutical regulations adherence.
Enterprise pricing model. SaaS subscription available for Lynx FacTOR (launched March 2025) and ColdStream Select. Pricing not publicly disclosed.
Sensitech offers professional services and expertise for cold chain implementation with focus on pharmaceutical supply chain optimization. Sensitech markets its cold chain solutions as validated for temperature-sensitive life sciences applications. Implementation includes device deployment across supply chain, cloud platform configuration, and integration with existing monitoring infrastructure.
Lynx FacTOR operates as SaaS with device-agnostic architecture, enabling integration with existing monitoring devices and data sources without replacement of current infrastructure. Platform consolidates data from multiple sources including temperature monitoring devices, batch stability databases, and compliance systems for automated product release evaluations.
Sensitech operates globally with 570+ employees across 6 continents supporting pharmaceutical customers. August 2024 acquisition of Monitoring Solutions business from Berlinger & Co. AG expanded product portfolio and global capabilities. Professional services team provides supply chain data protection and in-transit product release decision support with full traceability for regulatory compliance.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Strengths
No review platform lists this product; the points below are drawn from Sensitech's own materials rather than aggregated user feedback. Sensitech states that Carrier holds the largest market share in global cold chain monitoring through Sensitech and the Lynx Digital Platform. The device portfolio spans real-time monitoring (SmartMonitor, SmartView) and data loggers (Q-tag, TempTale Ultra), alongside cloud platforms for visibility and risk mitigation. Lynx FacTOR, launched March 2025, adds device-agnostic automated product release evaluation. Pharmaceutical-specific solutions include ColdStream Select and Lynx FacTOR, with GxP compliance support and GDP regulations adherence. Lynx FacTOR is 21 CFR Part 11 compliant. Sensitech operates with 570+ employees across 6 continents. A partnership with Qualcomm Technologies adds real-time monitoring capabilities, and the August 2024 acquisition of Berlinger & Co. AG's Monitoring Solutions business expanded the monitoring portfolio.
Limitations & Open Questions
No review platform lists this product, so common user complaints cannot be assessed from aggregated feedback. Only 21 CFR Part 11 is explicitly confirmed, for Lynx FacTOR. Other certifications — ISO, SOC 2, GAMP 5, EU Annex 11 — are not mentioned. Pricing is not publicly disclosed, which limits transparency for smaller pharmaceutical companies evaluating the platform. Sensitech markets "validated cold chain solutions", but does not specify IQ/OQ/PQ documentation availability. No pharmaceutical customer names are disclosed for reference or peer validation. API capabilities and integration methods are undisclosed. Implementation timelines and training programmes are undisclosed. GxP compliance is referenced in marketing content, but GMP, GLP, and GCP compliance status are not explicitly claimed.
Help the community
Share your experience with Sensitech anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackJump to section